Peter C. Hayes
#173,367
Most Influential Person Across History
Hepatology researcher
Peter C. Hayes's AcademicInfluence.com Rankings
Download Badge
Philosophy
Peter C. Hayes's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Biochemistry Stanford University
- Doctorate Medicine Harvard University
Similar Degrees You Can Earn
Why Is Peter C. Hayes Influential?
(Suggest an Edit or Addition)Peter C. Hayes's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- UK guidelines on the management of variceal haemorrhage in cirrhotic patients (2000) (483)
- Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes (2017) (429)
- Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study (2011) (361)
- Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure (1999) (339)
- Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score (2005) (326)
- Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. (2003) (284)
- Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. (2004) (253)
- Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed (2009) (253)
- Normal venous circulation of the gastroesophageal junction. A route to understanding varices. (1987) (215)
- Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS (2002) (209)
- Controlled clinical trial of injection sclerotherapy for active variceal bleeding (1989) (201)
- A randomized trial comparing transjugular intrahepatic portosystemic stent‐shunt with variceal band ligation in the prevention of rebleeding from esophageal varices (1997) (195)
- Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. (2010) (194)
- Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. (2004) (192)
- Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. (1999) (188)
- Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. (1995) (176)
- Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. (1995) (173)
- Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. (2000) (169)
- A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation (2000) (160)
- Cardiac morbidity and mortality related to orthotopic liver transplantation (2004) (157)
- Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure (2000) (149)
- Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. (2012) (142)
- Hepatotoxicity of herbal remedies. (1989) (141)
- Animal models of fulminant hepatic failure: A critical evaluation (2000) (133)
- Review article: omega‐3 fatty acids – a promising novel therapy for non‐alcoholic fatty liver disease (2009) (132)
- The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. (2002) (130)
- Psychological outcome and quality of life following liver transplantation: A prospective, national, single‐center study (2003) (125)
- Endoscopic use of human thrombin in bleeding gastric varices (2002) (123)
- Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. (1996) (121)
- The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure (2008) (120)
- The kidney plays a major role in the hyperammonemia seen after simulated or actual GI bleeding in patients with cirrhosis (2003) (119)
- Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in Humans (2009) (119)
- The Edinburgh Type 2 Diabetes Study: study protocol (2008) (116)
- Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension (2020) (115)
- Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia (2001) (114)
- Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis (2003) (112)
- Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause‐specific outcomes (2015) (110)
- The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations (2002) (109)
- A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. (1995) (106)
- Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis (2017) (104)
- Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. (2011) (101)
- Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy (2004) (99)
- The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. (2000) (99)
- Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation (2005) (96)
- Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection (1998) (94)
- Adherence to medication after liver transplantation in Scotland: A pilot study (2006) (93)
- Safety profile of autologous macrophage therapy for liver cirrhosis (2019) (90)
- aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. (2020) (87)
- Serum hyaluronan ‐ a non‐invasive test for diagnosing liver cirrhosis (2000) (87)
- Ten years’ follow-up of 472 patients following transjugular intrahepatic portosystemic stent-shunt insertion at a single centre (2004) (87)
- Circulating apoptotic and necrotic cell death markers in patients with acute liver injury (2011) (86)
- The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen. (2017) (85)
- Hepatic encephalopathy and ascites (1997) (83)
- Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents (2006) (83)
- A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland (2009) (83)
- Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. (1998) (83)
- Systematic review: prognostic tests of paracetamol‐induced acute liver failure (2010) (82)
- Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process. (1994) (81)
- Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland (2017) (81)
- Systematic review with meta‐analysis: coffee consumption and the risk of cirrhosis (2016) (81)
- Glutathione S-transferase in humans in health and disease. (1991) (80)
- A PILOT STUDY OF INDOCYANINE GREEN CLEARANCE AS AN EARLY PREDICTOR OF GRAFT FUNCTION (1994) (80)
- Anticipated regret and organ donor registration: A randomized controlled trial. (2016) (80)
- Guidelines on the management of ascites in cirrhosis (2020) (79)
- Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. (1988) (78)
- Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. (1996) (78)
- Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation (2008) (78)
- Age, anemia, and obesity-associated oxygen desaturation during upper gastrointestinal endoscopy. (1992) (77)
- Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease (2000) (76)
- Review article: hepatitis E—a concise review of virology, epidemiology, clinical presentation and therapy (2017) (76)
- Excess liver‐related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care (2011) (76)
- A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS) (1997) (75)
- Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. (1997) (75)
- Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'. (2002) (74)
- A controlled trial of oral propranolol compared with injection sclerotherapy for the long‐term magnagement of variceal bleeding (1990) (74)
- Smoking‐related morbidity and mortality following liver transplantation (2008) (73)
- Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: A prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus (2002) (72)
- Increased Whole-Body and Sustained Liver Cortisol Regeneration by 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Men With Type 2 Diabetes Provides a Target for Enzyme Inhibition (2011) (70)
- Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis. (1999) (67)
- Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. (1999) (64)
- The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. (1995) (64)
- Review article: recent advances in the management of bleeding gastric varices (2006) (64)
- The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users (1998) (63)
- Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae. (1996) (63)
- Esophageal motility in reflux disease before and after fundoplication: a prospective, randomized, clinical, and manometric study (2001) (62)
- Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. (1997) (61)
- The liver in typhoid fever: always affected, not just a complication. (1991) (60)
- Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. (2017) (60)
- A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP) (2019) (59)
- The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting. (2008) (59)
- Cytosolic and microsomal glutathione S-transferase isoenzymes in normal human liver and intestinal epithelium. (1989) (58)
- Liver biopsy bleeding time: An unpredictable event (1994) (57)
- Autonomic function in cirrhosis assessed by cardiovascular reflex tests and 24-hour heart rate variability. (1994) (57)
- Interferon treatment for chronic hepatitis C infection in hemophiliacs--influence of virus load, genotype, and liver pathology on response. (1996) (57)
- Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation (2002) (57)
- Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. (2013) (57)
- Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non‐invasive methods (1996) (57)
- Assessment of liver histology in patients with hepatitis C and normal transaminase levels. (1996) (55)
- Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension. (1988) (55)
- The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study. (2017) (54)
- Acute haemodynamic changes after oral carvedilol, a vasolidating beta-blocker, in patients with cirrhosis (1996) (53)
- Beta‐blockers in portal hypertension: new developments and controversies (2014) (53)
- Improvement of C3A cell metabolism for usage in bioartificial liver support systems. (2004) (53)
- Toxicology of ZnO and TiO2 nanoparticles on hepatocytes: Impact on metabolism and bioenergetics (2015) (52)
- Variceal band ligation versus beta-blockers for primary prevention of variceal bleeding: a meta-analysis (2007) (52)
- Portal hypertension and variceal haemorrhage (1997) (51)
- Human thrombin for the treatment of gastric and ectopic varices. (2012) (51)
- Isoleucine infusion during “simulated” upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients (2007) (50)
- Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications (2016) (50)
- Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis. (2003) (50)
- Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites (2005) (50)
- The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation (2005) (50)
- Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: Implications for treatment cost‐effectiveness (2013) (49)
- Altered peripheral vascular responses to exogenous and endogenous endothelin‐1 in patients with well‐compensated cirrhosis (2001) (48)
- Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient. (2017) (47)
- The effect of strenuous physical exercise on circulating blood lymphocytes and serum cortisol levels. (1981) (47)
- Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs. (2016) (47)
- Glutathione S-transferases in human liver cancer. (1991) (46)
- Bone marrow stem cells contribute to alcohol liver fibrosis in humans. (2010) (46)
- Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy (2006) (46)
- Ursodeoxycholic acid in the treatment of alcoholic liver disease (1991) (45)
- Polymorphisms in tumour necrosis factor α, interleukin-10 and transforming growth factor β1 genes and end-stage liver disease (2000) (45)
- Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis. (1997) (45)
- Acute kidney injury in acute liver failure: a review (2013) (44)
- The prediction of acute cellular rejection in orthotopic liver transplantation. (1999) (44)
- A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. (1995) (44)
- Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices (1989) (44)
- Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population. (2017) (43)
- Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy. (2016) (43)
- Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis. (1994) (42)
- Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial (2017) (42)
- Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up. (1994) (41)
- Laparoscopy and histology in the diagnosis of chronic liver disease. (1995) (41)
- Oral Amino Acid Load Mimicking Hemoglobin Results in Reduced Regional Cerebral Perfusion and Deterioration in Memory Tests in Patients with Cirrhosis of the Liver (2004) (40)
- Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population. (1997) (40)
- Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. (2009) (40)
- Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis (2012) (40)
- Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial (2006) (40)
- Effect and mechanism of action of isosorbide-5-mononitrate. (1988) (40)
- Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis. (2003) (40)
- Alcoholic hepatitis: from pathogenesis to treatment (2005) (40)
- The role of carvedilol in the management of portal hypertension (2010) (39)
- Prospective evaluation of haematological alterations following the transjugular intrahepatic portosystemic stent‐shunt (TIPSS) (1996) (39)
- Randomised clinical trial: standard of care versus early‐transjugular intrahepatic porto‐systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding (2020) (38)
- Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model (2015) (38)
- Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. (2003) (38)
- The correction of autonomic dysfunction in cirrhosis by captopril. (1997) (38)
- SARS-CoV-2 Infection and the Liver (2020) (38)
- Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis (2019) (38)
- Neutrophil activation in chronic liver disease (1996) (38)
- Biochemical prognostic markers of outcome in non-paracetamol–induced fulminant hepatic failure (2004) (37)
- Transjugular intrahepatic portasystemic stent shunting for control of acute and recurrent upper gastrointestinal haemorrhage related to portal hypertension. (1993) (37)
- Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. (1998) (37)
- A Biochemical Prognostic Model of Outcome in Paracetamol-Induced Acute Liver Injury (2005) (37)
- Middle cerebral artery blood flow velocity in patients with cirrhosis (1995) (36)
- Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland. (2014) (36)
- Hepatotoxicity of sodium stibogluconate in leishmaniasis (1993) (36)
- Treatment of uncontrolled intracranial hypertension in acute liver failure with moderate hypothermia (1999) (36)
- Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look‐Back Study) (2017) (36)
- Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland (2001) (35)
- Kidney plays a major role in ammonia homeostasis after portasystemic shunting in patients with cirrhosis. (2006) (35)
- Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. (1992) (35)
- Blotting techniques for the study of DNA, RNA, and proteins. (1989) (35)
- Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland (2012) (34)
- The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. (2011) (34)
- The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end‐stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose (2012) (33)
- Intrahepatic proliferation of ‘naive’ and ‘memory’ T cells during liver allograft rejection: primary immune response within the allograft (1998) (33)
- Palliative care for people with advanced liver disease: A feasibility trial of a supportive care liver nurse specialist (2018) (33)
- Low-Shear Modelled Microgravity Environment Maintains Morphology and Differentiated Functionality of Primary Porcine Hepatocyte Cultures (2010) (33)
- Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1. (2020) (33)
- Effect of propranolol on prevention of first variceal bleed and survival in patients with chronic liver disease (1994) (33)
- Glutathione S-transferases in alcoholic liver disease. (1990) (33)
- Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography (2017) (32)
- Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver (2017) (32)
- Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a β1‐integrin pathway (2004) (32)
- The use of hemostatic spray as an adjunct to conventional hemostatic measures in high-risk nonvariceal upper GI bleeding (with video). (2016) (32)
- Prevalence and markers of advanced liver disease in type 2 diabetes. (2012) (32)
- Coffee Consumption and Kidney Function: A Mendelian Randomization Study. (2019) (32)
- Glutathione S-transferase levels in autoimmune chronic active hepatitis: a more sensitive index of hepatocellular damage than aspartate transaminase. (1988) (32)
- Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting' [J. Clin. Virol. 41 (4) 2008 243-254]. (2008) (31)
- Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection (2016) (31)
- The simulated microgravity environment maintains key metabolic functions and promotes aggregation of primary porcine hepatocytes. (2001) (30)
- The role of duplex and colour Doppler ultrasound in the follow-up evaluation of transjugular intrahepatic portosystemic stent shunt (TIPSS). (1995) (30)
- Coffee and the liver: a potential treatment for liver disease? (2010) (30)
- The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland (1996) (30)
- In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. (1997) (29)
- Chronic Administration of Losartan, an Angiotensin II Receptor Antagonist, is not Effective in Reducing Portal Pressure in Patients with Preascitic Cirrhosis (2004) (29)
- Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: Pilot study (2004) (29)
- Development of an invasively monitored porcine model of acetaminophen-induced acute liver failure (2010) (29)
- Update of endoscopy in liver disease: more than just treating varices. (2012) (28)
- Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. (1994) (28)
- Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis (1998) (28)
- Review article: the management of acute variceal bleeding. (2003) (28)
- A case‐controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation (2011) (28)
- 1H NMR spectroscopy as a tool to evaluate key metabolic functions of primary porcine hepatocytes after cryopreservation (2002) (28)
- Pharmacokinetics of N‐acetylcysteine are altered in patients with chronic liver disease (1997) (27)
- The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection. (1998) (27)
- Hyperammonaemia in cirrhosis and Helicobacter pylori infection (1995) (26)
- Sensitivity to Change Following Liver Transplantation (2000) (26)
- Polymorphisms in tumour necrosis factor &agr;, interleukin‐10 and transforming growth factor &bgr;1 genes and end‐stage liver disease (2000) (26)
- Review: Non-alcoholic fatty liver disease: natural history, pathogenesis and treatment (2006) (25)
- Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma (2000) (25)
- Selective alteration of agonist-mediated contraction in hepatic arteries isolated from patients with cirrhosis. (2000) (24)
- Graft dysfunction following liver transplantation: role of free radicals. (1997) (24)
- Chronic Kidney Disease After Liver Transplantation for Acute Liver Failure Is Not Associated With Perioperative Renal Dysfunction (2011) (24)
- Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites. (1998) (24)
- Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan (2014) (23)
- Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy (1995) (23)
- Tacrolimus and cardiotoxicity in adult liver transplant recipients (1995) (23)
- Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis (2019) (23)
- Endoscopic therapy for bleeding gastric varices: to clot or glue? (2008) (23)
- Review article: the management of acute liver failure. (1998) (22)
- Profiling the Impact of Medium Formulation on Morphology and Functionality of Primary Hepatocytes in vitro (2013) (22)
- Controversies in management: Should methionine be added to every paracetamol tablet? (1997) (22)
- Neutrophil elastase: a determinant of endothelial damage and reperfusion injury after liver transplantation? (1996) (22)
- Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. (2008) (22)
- Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS) (1996) (21)
- The platelet count as a predictor of variceal hemorrhage in primary biliary cirrhosis. (1995) (21)
- Transjugular intrahepatic portosystemic stent shunt. (1995) (20)
- Pathogenesis and treatment of hepatic fibrosis: is cirrhosis reversible? (2011) (20)
- The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice (2016) (20)
- EUS-assisted thrombin injection for ectopic bleeding varices--a case report and review of the literature. (2012) (20)
- Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line. (2019) (20)
- Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. (2022) (20)
- Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991–2006 (2010) (20)
- Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. (1994) (19)
- Management of Transjugular Intrahepatic Portosystemic Shunt (TIPS)-associated Refractory Hepatic Encephalopathy by Shunt Reduction Using the Parallel Technique: Outcomes of a Retrospective Case Series (2011) (19)
- An improved ex vivo method of primary porcine hepatocyte isolation for use in bioartificial liver systems (2000) (19)
- Tipsitis: incidence and outcome–a single centre experience (2010) (19)
- Computerised system for the continuous measurement of azygos venous blood flow. (1992) (19)
- Glutathione S-transferase in human bile. (1989) (19)
- A drug therapy for the prevention of variceal haemorrhage (2001) (19)
- Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease (2020) (19)
- Peripheral eosinophil count both before and after liver transplantation predicts acute cellular rejection. (1997) (19)
- The influence of captopril, the nitrates and propranolol on apparent liver blood flow. (1985) (19)
- Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model. (2014) (19)
- Coeliac disease in the father affects the newborn (2001) (19)
- Considering adult living donor liver transplantation: A qualitative study of patients and their potential donors (2010) (19)
- Impact of transjugular intrahepatic portosystemic stent-shunt for secondary prophylaxis of oesophageal variceal haemorrhage: a single-centre study over an 11-year period (2002) (19)
- Functional outcome following liver transplantation—A pilot study (2008) (18)
- Glutathione S-transferase isoenzymes in human bronchoal veolar lavage: a possible early marker for the detection of lung cancer (1990) (18)
- Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study (2018) (18)
- Pretransplantation tumor necrosis factor‐α production predicts acute rejection after liver transplantation (2000) (18)
- (1)H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy. (2015) (18)
- Increasing organ donation via anticipated regret (INORDAR): protocol for a randomised controlled trial (2012) (18)
- Soluble adhesion molecules in immune mediated liver disease. (1995) (18)
- Carvedilol is associated with improved survival in patients with cirrhosis: a long‐term follow‐up study (2020) (18)
- Transjugular intrahepatic portosystemic stent-shunt (TIPSS) insertion as a prelude to orthotopic liver transplantation in patients with severe portal hypertension (1996) (18)
- Propranolol in chronic liver disease: a controlled trial of its effect and safety over twelve months. (1987) (18)
- Plasma glutathione S-transferase measurements in patients with alcoholic cirrhosis. (1987) (17)
- Systemic and regional changes in plasma endothelin following transient increase in portal pressure (2003) (17)
- Organic nitrates in portal hypertension. (1994) (17)
- Review article: advances in the management of patients with cirrhosis and portal hypertension‐related renal dysfunction (2014) (17)
- Sucralfate for the prevention of early rebleeding following injection sclerotherapy for esophageal varices. (1989) (17)
- Shunt insufficiency after transjugular intrahepatic portosystemic stent-shunt: the whens, whys, hows and what should we do about it? (1997) (16)
- Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? (2015) (16)
- GALLSTONES IN DIABETES-MELLITUS - PREVALENCE AND RISK-FACTORS (1992) (16)
- The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis. (1994) (16)
- Non‐invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study (2020) (16)
- Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function. (1989) (16)
- Carvedilol—A new nonselective beta blocker (2000) (16)
- Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfection. (2015) (16)
- Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort (2017) (16)
- Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect‐acting antiviral era (2017) (16)
- INFLUENCE OF PROPRANOLOL ON WEIGHT AND SALT AND WATER HOMOEOSTASIS IN CHRONIC LIVER DISEASE (1984) (15)
- Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro (2016) (15)
- REDUCTION IN THE POPULATION PREVALENCE OF HCV VIRAEMIA AMONG PEOPLE WHO INJECT DRUGS ASSOCIATED WITH SCALE-UP OF DIRECT-ACTING ANTIVIRAL THERAPY IN COMMUNITY DRUG SERVICES: REAL WORLD DATA. (2021) (15)
- Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury (2013) (14)
- Diagnostic laparoscopy and liver disease: experience of 200 cases. (1994) (14)
- Comparison of the Glasgow Alcoholic Hepatitis Score and the ABIC Score for the Assessment of Alcoholic Hepatitis (2010) (14)
- What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C? (2015) (14)
- Nondestructive Optical Toxicity Assays of 3D Liver Spheroids with Optical Coherence Tomography (2018) (14)
- Soluble adhesion molecules and interleukin-2 receptor concentrations in patients with autoimmune chronic hepatitis. (1995) (14)
- The use of transjugular intrahepatic portosystemic stent shunt in the management of acute oesophageal variceal haemorrhage (2006) (14)
- Platelet function in cirrhosis and the role of humoral factors (1997) (14)
- Acute changes in cerebral blood flow and metabolism during portasystemic shunting (2001) (14)
- Medical treatment of portal hypertension and oesophageal varices. (1983) (13)
- Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial) (2019) (13)
- Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis. (1997) (13)
- Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population‐level analysis (2018) (12)
- Contractile response of isolated human hepatic arteries to alpha-adrenoceptor agonists is not impaired in patients with cirrhosis. (1998) (12)
- Liver disease and drug disposition. (1992) (12)
- British Association for the Study of the Liver (1991) (11)
- Impaired gluconeogenesis in a porcine model of paracetamol induced acute liver failure. (2011) (11)
- Application of Impedance-Based Techniques in Hepatology Research (2019) (11)
- Primary culture of bovine gall bladder epithelial cells. (1993) (11)
- The cirrhosis epidemic in the UK: evaluating the causes in a European context (2007) (11)
- Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study (2020) (11)
- Transjugular intrahepatic portosystemic shunt in the prevention of rebleeding in oesophageal varices (2006) (11)
- Vasoactive effects of aprotinin. (1992) (10)
- A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices (1998) (10)
- 6 New immunosuppressive treatment in transplantation medicine (1994) (10)
- Transient segmental liver ischaemia after polytetrafluoroethylene transjugular intrahepatic portosystemic stent-shunt procedure. (2005) (10)
- Transjugular intrahepatic portosystemic stent shunts. (1994) (10)
- Transjugular intrahepatic portosystemic stent shunt placement in a patient with cystic fibrosis complicated by portal hypertension. (2000) (10)
- Review article: the pathophysiology and pharmacological treatment of portal hypertension (1992) (10)
- The natural history of parallel transjugular intrahepatic portosystemic stent shunts using uncovered stent: the role of host‐related factors (2006) (9)
- Variceal haemorrhage and post-traumatic stress disorder. (1999) (9)
- Evidence of hydrogen ion secretion from the human gall bladder in vitro. (1992) (9)
- Persistently elevated troponin I in paracetamol hepatotoxicity: Association with liver injury, organ failure, and outcome (2013) (9)
- Liver biopsy findings in patients with alcoholic liver disease complicated by chronic hepatitis C virus infection. (1995) (9)
- Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs (2021) (9)
- Protein synthesis is severely diminished following a simulated upper GI bleed in patients with cirrhosis. (2008) (9)
- Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites. (1992) (8)
- Health effects of alcohol and alcoholism. (1999) (8)
- Hand skin temperature changes in patients with chronic liver disease. (1994) (8)
- Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients (1998) (8)
- Benzodiazepine-Like Substances and Hepatic Encephalopathy (1997) (8)
- The Management of Bleeding from Anorectal Varices (2017) (8)
- Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease (2018) (8)
- Influence of cyclic guanosine monophosphate changes on hemodynamics after reperfusion in liver transplantation. (1997) (8)
- Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis. (1995) (8)
- Inpatient hospital burden of hepatitis C‐diagnosed patients with decompensated cirrhosis (2018) (8)
- Platelet basal cytosolic calcium: the influence of plasma factors in cirrhosis. (1996) (7)
- OC-003 Multicentre Randomised Controlled Study Comparing Carvedilol with Endoscopic Band Ligation in the Prevention of Variceal Rebleeding (2013) (7)
- Primary prophylaxis of variceal bleeding (2018) (7)
- Changes in cerebral metabolism in patients with acute liver failure (ALF) and uncontrolled intracranial hypertension treated with moderate hypothermia (1998) (7)
- A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: A prospective, randomized study (2001) (7)
- The significance of fat droplet size and the prognostic value of hyaluronic acid in non-alcoholic fatty liver disease (NAFLD): a biopsy based analysis (2011) (7)
- An elevated neutrophil–lymphocyte ratio is associated with adverse outcomes following single time-point paracetamol (acetaminophen) overdose: a time-course analysis (2014) (7)
- The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study (2020) (7)
- Radioimmunoassay Measurements of the Human Glutathione S-Transferases (1990) (7)
- Encephalopathy and nitrogen metabolism in liver failure (2003) (6)
- Early TIPS for portal hypertensive related bleeding: Is resource or education the reason for failure to show clear survival benefit? (2017) (6)
- Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection (2021) (6)
- Endoscopic diagnosis, grading and predictors of bleeding in esophageal and gastric varices (2005) (6)
- Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity (2021) (6)
- Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005‐2016: a national database linkage study (2019) (6)
- Alcohol withdrawal requiring massive prolonged benzodiazepine infusion. (2007) (6)
- Lichen planus and Crohn's disease. (1997) (6)
- Small bowel capsule endoscopy and portal hypertensive enteropathy in cirrhotic patients: results from a tertiary referral centre. (2016) (6)
- Diagnosis of hepatic encephalopathy: Will in vivo proton MRS play a role? (1999) (6)
- Comparison of Bioenergetic Activity of Primary Porcine Hepatocytes Cultured in Four Different Media (2004) (6)
- Reclaiming their lives: The decision-making process in living liver donation – An interpretative phenomenological case study analysis of one couple (2014) (6)
- 266 Mobilization of pluripotent haematopoietic stem cells occurs in alcoholic hepatitis and is associated with an improved clinical outcome (2003) (6)
- OTU-09 Use of early-TIPSS in patients with oesophageal variceal bleeding, a UK dual-centre randomised control trial (2019) (5)
- Experiences of diagnosis, stigma, culpability and disclosure in male patients with hepatitis C virus: An interpretative phenomenological analysis (2019) (5)
- Small bowel capsule endoscopy and portal hypertensive enteropathy in cirrhotic patients: results from a tertiary referral centre. (2016) (5)
- Effect of Hepatocellular Carcinoma Surveillance Programmes on Overall Survival in a Mixed Cirrhotic UK Population: A Prospective, Longitudinal Cohort Study (2021) (5)
- Section Review Anti-infectives: Current perspectives on the treatment and prevention of hepatitis C infection (1996) (5)
- A new method for semi-automated quantitation of E-rosettes using a particle size analyser (Coulter Channelyzer). (1979) (5)
- POSTER SESSION ABSTRACTS (1996) (5)
- Explorer H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy (2015) (5)
- Living liver donation: Attitudes of the general public and general practitioners in Scotland (2008) (5)
- An unusual case of gustatory sweating (1982) (5)
- ATU-06 Does the timing of TIPSS in patients with acute oesophageal variceal bleeding alter patient outcome? (2019) (4)
- Validation of Reference Genes for Gene Expression Studies by RT-qPCR in HepaRG Cells during Toxicity Testing and Disease Modelling (2020) (4)
- Cytosolic andmicrosomal glutathione S-transferase isoenzymes innormal humanliver andintestinal epithelium (1989) (4)
- Glutathione S-transferase isoenzymes in human bronchoalveolar lavage: a possible early marker for the detection of lung cancer. (1990) (4)
- Direct measurement of post‐prandial portal haemodynamics in cirrhotic patients with a transjugular intrahepatic portosystemic stent‐shunt (1998) (4)
- 801 Brain production of pro-inflammatory cytokines in patients with acute liver failure and uncontrolled intracranial hypertension: evidence of disrupted blood brain barrier? (2003) (4)
- Reduction in the incidence of hepatitis C-related decompensated cirrhosis associated with national scale-up of direct-acting antiviral therapies targeting patients with advanced liver fibrosis (2018) (4)
- Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding—long‐term follow‐up of a randomised control trial (2022) (4)
- Similarity of response to vasoconstrictors in porcine hepatic and human hepatic and mesenteric arteries in vitro (1995) (4)
- Free radical production following vascular reperfusion (1993) (4)
- Extrahepatic manifestations of alcoholic liver disease. (1993) (4)
- Liver biopsy in haemophilia. (1997) (4)
- Reversible internal hydrocephalus complicating diabetic keto-acidosis. (1984) (4)
- Is this the end for protocol early posttransplant liver biopsies? (2002) (4)
- Comparison of Propranolol with Injection Sclerotherapy in Prevention of Rebleeding from Oesophageal Varices in Cirrhotic Patients (2012) (4)
- Contact sensitization pretransplantation predicts acute hepatic allograft rejection (2001) (4)
- The coming of age of band ligation for oesophageal varices (1996) (4)
- UEG Week 2016 Poster Presentations (2016) (4)
- The hands in alcoholic liver disease. (1991) (4)
- Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus (1998) (4)
- IMMUNOLOCALISATION OF GLUTATHIONE S-TRANSFERASE IN HUMAN RENAL AND LIVER DISEASE (1990) (4)
- Bradykinin Does Not Contribute to Peripheral Vascular Tone in Patients With Cirrhosis and Ascites (2006) (4)
- Treating bleeding oesophageal varices with vasoactive agents:good value for money? (2007) (3)
- 227 Management of ectopic varices: The edinburgh experience (2006) (3)
- Effect of time to pre‐emptive transjugular intrahepatic portosystemic shunt on patient outcome, a UK multicentre cohort study (2022) (3)
- The decision-making value of magnetic resonance cholangiopancreatography in patients seen in a referral center for suspected biliary and pancreatic disease (2001) (3)
- Management of gastro-oesophageal varices. (2002) (3)
- Prophylactic injection sclerotherapy for esophageal varices: a critical appraisal. (1988) (3)
- Gastric mucosal bleeding time in cirrhosis. (1994) (3)
- Microgravity environment in a rotary cell culture system (RCCS) promotes cell aggregation and maintains differentiation and proliferation of primary porcine hepatocytes (1998) (3)
- Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study (2021) (3)
- Markedly Increased High-Mobility Group Box 1 Protein in a Patient with Small-for-Size Syndrome (2014) (3)
- Thrombin Is an Effective and Safe Therapy in the Management of Bleeding Gastric Varices. A Real-World Experience (2021) (3)
- Addition of hyaluronic acid to the FIB‐4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study (2021) (3)
- 35 Role of endothelin-1 in the maintenance of systemic and portal haemodynamics in patients with cirrhosis: A randomised double blind placebo-controlled haemodynamic study of endothelin-A and endothelin-B receptor antagonism (2004) (3)
- Examination of cytochrome P450 content of primary porcine hepatocyte cultures with various media formulations for use in bioartificial liver devices (2002) (3)
- Anticipated Regret and Organ Donor Registration (2014) (3)
- Drug therapy of portal hypertension and oesophageal varices. (1984) (3)
- Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? (2016) (2)
- The Use of Three-Dimensional Reconstruction Software in Oesophageal Capsule Endoscopy: A Pilot Study from Edinburgh (2014) (2)
- Effect of transjugular intrahepatic portosystemic stent-shunt (TIPSS) upon liver function in patients with cirrhosis (1997) (2)
- THE EFFECT OF FREE FATTY ACID AND REACTIVE OXYGEN SPECIES ON CIDEB EXPRESSION IN IN VITRO MODEL OF STEATOSIS (2010) (2)
- Arginine, citrulline, and nitric oxide metabolism in patients with liver failure and the effect of intervention with hypothermia and transplantation (2006) (2)
- Comparison of the effects of long-term pioglitazone and rosiglitazone therapy on liver enzymes in type 2 diabetes (2011) (2)
- Blood pressure and liver cirrhosis. (1990) (2)
- Safety of propranolol in portal hypertension. Conventional and long acting formulations. (1989) (2)
- Hazards of biliary tract surgery. (1981) (2)
- [138] LACTATE ALONE IS NOT AN ACCURATE PREDICTOR OF POOR PROGNOSIS IN PARACETAMOL INDUCED FULMINANT LIVER FAILURE (2007) (2)
- Modelling the impact of incarceration and prison-based HCV treatment on HCV transmission among people who inject drugs in Scotland (2017) (2)
- Carvedilol is associated with improved survival in patients with decompensated cirrhosis (2017) (2)
- Pathophysiology and management of portal hypertension. 1: Variceal haemorrhage. (1997) (2)
- Oxygen plasma substrate and specific nanopattern promote early differentiation of HepaRG progenitors. (2020) (2)
- Acute liver failure: complications and current management. (1998) (2)
- Endoscopic Management of Acute Variceal Bleeding (2017) (2)
- The effect of alcohol on acid secretion by the bovine gall bladder in vitro. (1995) (2)
- Cardiac and pulmonary issues in LT assessment candidates. (2014) (2)
- Impaired central but stimulated humoral regulation of vascular tone in patients with cirrhosis and ascites (1996) (2)
- Interferon treatment for chronic HCV infection in haemophiliacs (1995) (2)
- Increased cerebral and peripheral vasodilation, and whole body nitric oxide production after insertion of a transjugular intrahepatic portal-systemic stent in patients with cirrhosis. (2003) (2)
- Baseline neutrophil to lymphocyte ratio can identify favourable corticosteroid response in alcoholic hepatitis (2017) (2)
- Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? (2003) (2)
- Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites. (1997) (2)
- The inhibition of growth due to fulminant hepatic failure serum is notdue to increased apoptosis/necrosis (2000) (2)
- Su1295 Randomized Prospective Trial of TransNasal Versus Standard Upper Diagnostic Endoscopy Under Local Anaesthetic: Interim Analysis of Endoscopy Quality, Patient Acceptability and Tolerability (2012) (2)
- Hepatic vein cannulation and stable isotope tracer infusion reveals that liver cortisol regeneration by 11[beta]-HSD1 is sustained in obese men with type 2 diabetes mellitus, providing a target for enzyme inhibition (2010) (2)
- Gastric wall invasion following transjugular intrahepatic portosystemic stent shunt insertion for variceal bleeding. (2006) (2)
- Acetaminophen-induced fulminant hepatic failure results in an SDF-1 mediated 'all or nothing' haematopoietic stem cell response. (2005) (2)
- Endoscopic ultrasound assessment of gastrointestinal polypoid lesions of indeterminate morphology in patients with portal hypertension (2018) (2)
- 787 Worsening of cerebral hyperemia in acute liver failure with severe hepatic encephalopathy following terlipressin (2003) (2)
- Gastrointestinal bleeding: Endoscopic cyanoacrylate therapy for gastric variceal bleeding (2010) (2)
- Acid-Base and Electrolyte Regulation in the Bovine Gall-Bladder Bile Model (1994) (2)
- Regional variations in the concentrations of ketone bodies in cirrhosis and hepatic encephalopathy: a study in patients with TIPSS (2011) (2)
- Acute liver failure serum reduces hepatocyte-matrix adhesion by a cell death-independent mechanism (2001) (2)
- Contribution of endothelin-1 to the circulatory and renal abnormalities in patients with cirrhosis and portal hypertension. (2002) (2)
- Evidence of impaired acidification in vitro by human gall bladder mucosa in patients with gallstone disease (1993) (2)
- Stratified efficacy of first -line therapy to prevent first variceal bleeding according to previous decompensation of cirrhosis. A competing-risk meta-analyses of individual participant data (2022) (2)
- P337 HEPATOPROTECTIVE EFFECT OF HUVEC CELLS IN AN IN VITRO HEPATIC CO-CULTURE MODEL OF ACETAMINOPHEN TOXICITY (2014) (1)
- Autonomic function tests in cirrhosis (1991) (1)
- Noradrenaline response to exercise and autonomic dysfunction in cirrhosis (1994) (1)
- Hypothermia for fulminant hepatic failure: A cool approach to a burning problem (2000) (1)
- Hyperammonemia following a simulated bleed results in neuropsychological deterioration and regional cerebral deactivation. (1999) (1)
- Clinicopathological characteristics of subpopulations serum RT-PCR negative and serum RT-PCR positive for hepatitis C virus (1997) (1)
- Are Cirrhosis and its Complications Inevitable in Hepatitis C Virus Infection? (2000) (1)
- Effect of Glyceryl Trinitrate, Isosorbide-5-Mononitrate, and Propranolol on Apparent Liver Blood Flow (1985) (1)
- PTFE covered transjugular intrhepatic portosystemic stent-shunts (TIPSS): early clinical experience (2001) (1)
- Poster Sessions (2015) (1)
- Preventing Rebleeding in 2010 (2010) (1)
- Aids to clinical examination (1986) (1)
- Shunt insufficiency after TIPSS (1998) (1)
- Analysis of serial serum alpha-fetoprotein concentrations in patients with cirrhosis (1994) (1)
- OC-007 Oxidative Stress Rather than Triglyceride Accumulation Perturbs Glutathione Metabolism in an in Vitro Model of Cellular Steatosis (2013) (1)
- Portal hypertension revisited. (1995) (1)
- The cytokines, MMP-9 and SDF-1, play a central role in regulating the mobilisation of CD34+stem cells in human liver injury. (2004) (1)
- Training and Validation of an Artificial Neural Network to predict early mortality in patients undergoing the transjugular intrahepatic portosystemic stent shunt (TIPSS) for variceal haemorrhage: Analysis of data on 398 patients from two centres (1997) (1)
- No: The risks are not well enough known (1997) (1)
- Study of regional neutrophil chemotaxis in chronic liver diseases (CLD) (2001) (1)
- GS-11-Baseline neutrophil-to-lymphocyte ratio indicates both prevalent and incident infection and acute kidney injury, and is related to corticosteroid Lille response in alcoholic hepatitis (2019) (1)
- Editorial: when to start carvedilol in cirrhosis—time to reconsider? (2021) (1)
- Management of portal hypertension, Budd–Chiari syndrome and portal vein thrombosis (2015) (1)
- Transjugular intrahepatic porto-systemic stent-shunts (TIPSS): Results of long term follow-up of 303 patients. (1998) (1)
- Pregnancy in Patients with Established Liver Cirrhosis – An Uncommon but High-Risk Situation (2017) (1)
- Emergency transjugular intrahepatic portasystemic stent shunts to control acute variceal haemorrhage resistant to sclerotherapy (1994) (1)
- Uptake of interferon‐free DAA therapy among HCV‐infected decompensated cirrhosis patients and evidence for decreased mortality (2021) (1)
- Changing packaging does not reduce serious paracetamol (acetaminophen) poisoning. (2000) (1)
- Hospitalisation of hepatitis C diagnosed persons in Scotland for decompensated cirrhosis: a population-based record-linkage study (2008) (1)
- Portal Hypertension: A Multidisciplinary Approach to Current Clinical Management. (1999) (1)
- Towards understanding the mechanisms of chlorpromazine-induced hepatic toxicity using a human HepaRG-based model (2018) (1)
- Towards non-invasive 3D hepatotoxicity assays with optical coherence phase microscopy (2015) (1)
- Pathways of T cell mediated cytotoxicity in hepatic allograft rejection (1998) (1)
- Hyporesponsiveness to alpha-adrenoceptor agonists in cirrhotic patients is not evident when human hepatic and mesenteric arteries are studied in vitro (1996) (1)
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C (2001) (1)
- Evidence for altered renal blood flow autoregulation in cirrhosis. (2003) (1)
- THE HANDS IN ALCOHOLIC LIVER-DISEASE - RESPONSE (1991) (1)
- Simulation of a upper gastrointestinal bleed in patients with cirrhosis of the liver: a model to study the metabolism of hepatic encephalopathy (1998) (1)
- Response to Marino et al J Hep 2019 study: The reported "clear cut time association between interferon-free treatment and HCC" is anything but clear cut. (2019) (1)
- The use of endoscopic band ligation for the prophylaxis of variceal haemorrhage. (1999) (1)
- A rise in cerebral blood flow precedes intracranial hypertension in patients with acute liver failure (ALF). (2001) (1)
- ROLE OF ENDOSCOPIC ULTRASOUND IN THE MANAGEMENT OF LIVER DISEASE PATIENTS WITH ECTOPIC OR GASTRIC VARICES (2009) (1)
- NMR studies found that a commercially supplied standard reference purported to be Withanolide D was instead Withanolide A (2007) (1)
- Serum from patients with acute liver failure decreases cellular adhesion prior to inducing apoptotic cell death; Important implications for hepatocyte transplantation. (2001) (1)
- The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large ‘real world’ cohort (2015) (1)
- Does the use of Non-Selective Beta-Blockers in Cirrhosis Patients with Ascites Result in Increased Mortality? (2016) (1)
- Haemodynamic responsetointravenous vasopressin andnitroglycerin inportal hypertension (1988) (1)
- Postoperative jaundice. (1989) (1)
- Investigation and management of acute diarrhoea. (1996) (1)
- Massive T wave changes following a combined kidney and liver transplant in a young female with cirrhosis. (1999) (1)
- Grading alcoholic hepatitis (2005) (1)
- 824 TRANSORBITAL SONOGRAPHIC EVALUATION OF OPTIC NERVE SHEATH DIAMETER IN ACUTE LIVER FAILURE (2010) (1)
- Paper alert. (2017) (1)
- Human cord-blood derived cells can differentiate into hepatocytes in the NOD-SCID mouse liver with no evidence of cellular fusion. (2002) (1)
- RANDOMISED PROSPECTIVE TRIAL OF TRANSNASAL VS STANDARD UPPER DIAGNOSTIC ENDOSCOPY UNDER LOCAL ANAESTHETIC (2012) (1)
- Enhanced sensitivity to endothelin-1 in hepatic arteries from patients with cirrhosis. (1999) (1)
- Prevention of Recurrent Variceal Bleeding: Pharmacologic Measures (1992) (1)
- PWE-100 A clinical trial investigating the effect of omega-3 fatty acids on non-alcoholic fatty liver disease (2015) (1)
- Neutrophil chemotaxis and expression of CXCR1 and CXCR2 in patients with acetaminophen induced fulminant hepatic failure (FHF) (2001) (1)
- The effect of hypothermia on primary porcine hepatocyte metabolism monitored by (1H) nuclear magnetic resonance spectroscopy (2003) (1)
- Intravenous amiodarone in atrial fibrillation complicating myocardial infarction (1982) (1)
- An aid to reducing unnecessary investigations (1981) (1)
- Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha (2001) (1)
- Altered peripheral vascular responses to vasoactive mediators in patients with pre-ascitic cirrhosis: role of nitric oxide (2001) (1)
- A method for standardised resuspension of lymphocyte E-rosettes. (1977) (1)
- TIPS: the immediate problems solved. (1995) (1)
- LAPAROSCOPIC LIVER-BIOPSY IN THE INVESTIGATION OF HEMOPHILIACS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION (1995) (1)
- Establishing the Edinburgh Model: Dose to Injury Response in a Large Animal Infusion Model of Paracetamol-Induced Acute Liver Failure (2016) (1)
- Transplantation for alcoholic liver disease: lessons from the explant? (2003) (1)
- Tissue engineering of vascularised human liver organoids: study of morphology phenotypic expression and metabolomics of transitional co-cultures of hepatic/endothelial progenitors (2011) (0)
- Letter: non‐selective beta‐blockers in cirrhosis—effect beyond portal hypertension. Authors' reply (2022) (0)
- Cystatin C and eGFR can be utilised in the prediction of cardiovascular (CV) and non cardiac death post orthotopic liver transplantation (OLT) (2013) (0)
- A study of breath metabolome in Non-alcoholic fatty liver disease (2018) (0)
- Electronic-nose breath print distinguishes non-alcoholic fatty liver disease from healthy lean control: A pilot study (2018) (0)
- Non-Alcoholic Fatty Liver Disease: Pathogenesis Directed Therapy – the Way Forward (2007) (0)
- Paper Alert. (2019) (0)
- Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: New modes of immunosuppression for the prevention of allograft rejection (1996) (0)
- Plasma intestinal alkaline phosphatase in the diagnosis of intrahepatic cholestasis (1991) (0)
- O3 Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding – long term follow-up of a multicentre randomised controlled study (2020) (0)
- PTU-024 Do iron studies on admission predict outcome in patients with acute liver failure? (2019) (0)
- Criteria predictive of outcome in non paracetamol induced acute liver failure using 1H nuclear magnetic resonance spectroscopy. (2000) (0)
- Reply: (2009) (0)
- Development of a novel 3D organotypic human HepaRG-based non-invasive imaging platform for pre-clinical drug screening (2017) (0)
- Increased soluble interleukin-6 receptor in patients with liver-disease: evidence for hepatic production (1994) (0)
- Editorial: are earlier referrals to transplant centres responsible for improved outcomes in patients with acute liver failure? Authors’ reply (2017) (0)
- Synchronisation of HEPG2 cells in G(0)/G(1) enhances the cyto-inhibitory effect of fulminant hepatic failure serum. (2000) (0)
- [164] CHRONIC RENAL FAILURE POST LIVER TRANSPLANT; PREVALENCE AND RATE OF DECLINE (2007) (0)
- Paper alert (2018) (0)
- OUTCOMES FOLLOWING LIVER TRANSPLANT FOR ACUTE LIVER FAILURE SECONDARY TO ACETAMINOPHEN OVERDOSE IS SIMILAR TO THOSE OF OTHER CAUSES (2009) (0)
- 222 CARDIOVASCULAR EVENTS IN ORTHOTOPIC LIVER TRANSPLANT ASSESSMENT CANDIDATES: AN ANALYSIS OF RISK FACTORS (2008) (0)
- Portal Hypertension: A Management Problem (2011) (0)
- P336 HEPATOCYTES IMPROVE THEIR DRUG METABOLIC ACTIVITY WITH THE PRESENCE OF ENDOTHELIAL CELLS IN AN IN VITRO HEPATIC CO-CULTURE MODEL OF ACETAMINOPHEN TOXICITY (2014) (0)
- 1 The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis (2003) (0)
- HEPSYS-IV PROTEOMICS PROFILING OF HUMAN ALF PLASMA REVEALS CLINICALLY-RELEVANT PROTEIN EXPRESSION PATTERNS (2013) (0)
- Managing Acute and Chronic Seronegative Liver Disease (2020) (0)
- CORRIGENDA (2011) (0)
- Coffee intake linked to improved SVR in patients undergoing treatment for hepatitis C (2011) (0)
- Isosorbide-5-Mononitrate in Portal Hypertension and Cirrhosis: A Study of the Effect and Mechanism of Action (1987) (0)
- Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial (2001) (0)
- SKIN TESTS PREDICT ACUTE CELLULAR REJECTION IN LIVER TRANSPLANTATION (1998) (0)
- GRAFT FUNCTION FOLLOWING LIVER-TRANSPLANTATION IS DETERMINED BY THE DEGREE OF REPERFUSION INJURY AND IS PREDICTED EARLY BY INDOCYANINE GREEN CLEARANCE (1995) (0)
- A curious case of unilateral spider nevi, cirrhosis and stroke: unilateral nevoid telangiectasia syndrome. (2013) (0)
- The relationship between reactive oxygen species, insulin resistance and nonalcoholic fatty liver disease. A study using in vitro model (2008) (0)
- Quantifying the benefit of non-selective beta-blockers in the prevention of hepatic decompensation: a Bayesian re-analysis of the PREDESCI trial. (2023) (0)
- Is the prothrombin time still useful for assessing fulminant hepatic failure (2002) (0)
- 985 THE IMPACT OF LONG-TERM PIOGLITAZONE THERAPY ON ABNORMAL LIVER ENZYMES IN TYPE 2 DIABETES (2008) (0)
- 477 A RISK STRATIFICATION MODEL FOR MANAGING PATIENTS WITH SEVERE PARACETAMOL-INDUCED ACUTE LIVER INJURY (2009) (0)
- Worsening of cerebral hyperaemia in acute liver failure (ALF) with terlipressin (2003) (0)
- P28 Changes in serum bilirubin within the first four days of admission do not reflect outcome in severe alcoholic hepatitis (2020) (0)
- Endoscopy in Liver Disease (2017) (0)
- Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis (2023) (0)
- THE EYE AS A NON-INVASIVE WINDOW TO THE MICROCIRCULATION IN CIRRHOSIS: A PROSPECTIVE COHORT STUDY (2019) (0)
- P2-122 Response and predictors of response, to pegylated interferon and ribavirin for chronic hepatitis C patients in Scotland: alanine aminotransferase (ALT) and gamma glutamyl transferase (GGT) are valuable pre-treatment markers of an SVR in routine clinical practice (2011) (0)
- Argon plasma coagulation is an effective treatment in cirrhosis- related gastric antral vascular ectasias (2011) (0)
- Oesophageal variceal haemorrhage: a practical approach. (1994) (0)
- Explorer Increasing organ donation via anticipated regret ( INORDAR ) : protocol for a randomised controlled trial (2017) (0)
- Irish Society of Gastroenterology (1995) (0)
- British Association for the Study of the Liver Meeting (2000) (0)
- Exposure to the SARS-CoV-2 spike protein in an in vitro model of steatosis enhances hepatocyte oxidative stress: implications for COVID-19 and accelerated disease progression (2022) (0)
- 171 AN ASSESSMENT OF CORONARY ARTERY CALCIFICATION (CAC) IN ORTHOTOPIC LIVER TRANSPLANT (OLT) PATIENTS (2013) (0)
- Pollution-derived nanoparticles have a profound effect on hepatocyte bioenergetics. (2005) (0)
- Paper alert. (2017) (0)
- Tryptophan metabolism in cirrhotic patients with and without manifestations of overt hepatic encepahlopathy (2011) (0)
- Role of nitric oxide in the cytosolic calcium changes to platelets from patients with cirrhosis (1995) (0)
- Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? (2015) (0)
- Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: an international comparison (2017) (0)
- PWE-144 Small Bowel Capsule Endoscopy In Patients With Cirrhosis: The Edinburgh Experience (2014) (0)
- OP04 Circulating levels of the long pentraxin PTX3, but not hepatocyte derived C-reactive protein, correlate with severity following human acute liver injury (2010) (0)
- Human Organotypic Co-culture Modeling Enhances Hepatic Functionality, Phenotypic Stability and Modulates Hepatotoxicity Parameters in Response to Acetaminophen (2014) (0)
- Hepatitis G virus in patients with hepatocellular carcinoma. (1998) (0)
- P898 DELETERIOUS OUTCOME IN PATIENTS WITH ACUTE LIVER INJURY (2014) (0)
- Exhaled Breath Profiling by Electronic Nose as a Novel Non-Invasive Method for Assessment of Chronic Liver Disease: Proof of Principle Study (2016) (0)
- Haemodynamic effects of chronic administration of losartan, an angiotensin II receptor anatagonist, in patients with cirrhosis and portal hypertension (2002) (0)
- 455 PREDICTORS OF SPONTANEOUS SURVIVAL IN FULMINANT HEPATIC FAILURE PATIENTS MEETING KING'S COLLEGE CRITERIA (2009) (0)
- P06 Role of serum hyaluronic acid in predicting mortality in patients with chronic liver disease (2011) (0)
- THU-261-Validation of the pre-treatment neutrophil-to-lymphocyte ratio to predict response to corticosteroids in severe alcoholic hepatitis (2019) (0)
- Anticipated Regret and Organ Donation 1 Anticipated Regret and Organ Donor Registration : a randomised controlled trial Running (2019) (0)
- Glutathione s-transferases in the pancreas (1993) (0)
- Role of inflammation and infection in the pathogenesis of human acute liver failure (2016) (0)
- Explorer Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection (2017) (0)
- Tipssing the Scales for Patients with Cirrhosis (2001) (0)
- Focusing on the patient: impact of new UK guidelines on treatment of chronic hepatitis C (2012) (0)
- 943 DO ABNORMAL LIVER FUNCTION TESTS IMPROVE WITH INSULIN THERAPY IN TYPE 2 DIABETES (2008) (0)
- Development of a fully anaesthetised porcine model of acetaminophen-induced acute liver failure. (2001) (0)
- PMO-122 Eicosapentaenoic acid is effective at reducing hepatocyte triglyceride content of untreated C3A cells but is not effective in two models of cellular steatosis (2012) (0)
- Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro (2016) (0)
- Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens (2001) (0)
- 216 ESTIMATED GLOMERULAR FILTRATION RATE MAY BE SUPERIOR TO CREATININE IN PREDICTING DEATH ON THE WAITING LIST FOR LIVER TRANSPLANTATION (2008) (0)
- IN VITRO HEPATOCYTE REACTIVE OXYGEN SPECIES PRODUCTION IS NOT RELATED TO THE DEGREE OF FAT ACCUMULATION (2008) (0)
- Letter: improve survival! Place early pre-emptive TIPSS in high-risk variceal bleeders-Authors' reply. (2020) (0)
- ASSOCIATIONS WITH NON-COMPLIANCE OR CHRONIC REJECTION IN PATIENTS TRANSPLANTED FOR ACUTE LIVER FAILURE (2009) (0)
- Image Quantification for Diagnosis of Fatty Liver Disease: Magnetic Resonance Imaging and Ultrasound (2009) (0)
- P44 Liver ultrasound practice is heterogenous and failing to highlight clinically significant liver disease (2022) (0)
- OC-045 Randomised prospective trial of transnasal vs standard upper diagnostic endoscopy under local anaesthetic: interim analysis of endoscopy quality, patient acceptability and tolerability (2012) (0)
- Does Alcohol Dependency Explain Differences in Rates of Decompensated Cirrhosis among People with a Hepatitis C Notification? An International Comparison (2016) (0)
- Can cytokine manipulation of haematopoietic stem cells induce hepatocytic differentiation (2001) (0)
- Reversal of Fischer's ratio in an anaesthetised porcine model of fulminant hepatic failure. (2002) (0)
- Erratum to: Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? (2016) (0)
- Portal hypertension and variceal bleeding (2020) (0)
- Media containing energetics substrates affect mitochondria biogenesis and increase metabolism in the C3A hepatocyte cell line (2006) (0)
- Pathophysiology , Aetiology and Prevalence of Anorectal Varices (2017) (0)
- PTH-104 The increasing burden of diabetes on the scottish liver transplantation service (2018) (0)
- Glutathione S-transferase isozymes in alcoholic liver disease (1990) (0)
- Serum from patients with acute liver failure decreases T cell differentiation of human stem cells (2004) (0)
- 8 year analysis of the Scottish liver transplant unit acute liver failure database. (2000) (0)
- 938 ARGON PLASMA COAGULATION IS AN EFFECTIVE TREATMENT IN CIRRHOSIS-RELATED GASTRIC ANTRAL VASCULAR ECTASIAS (2011) (0)
- Authors' response to Dr Reiter. (2013) (0)
- Quantifying in vivo extra-adrenal cortisol production and dysregulation in human metabolic disease (2012) (0)
- 214 DOES THE SYSTEMIC INFLAMMATORY RESPONSE PLAY A ROLE IN THE PATHOGENESIS OF RENAL FAILURE IN ACUTE LIVER FAILURE (2008) (0)
- ASSOCIATION OF ACUTE REJECTION IN LIVER TRANSPLANTATION WITH TUMOUR NECROSIS FACTOR ALPHA-308 POLYMORPHISM (1999) (0)
- Acute liver failure serum causes apoptotic cell death by down-regulation of beta(1)-integrin activity (2002) (0)
- Role of Impedance Based Cellular Assays in the Hepatology Research (2020) (0)
- PMO-194 Polypoid lesions in the UGI tract in patients with portal hypertension; EUS before you biopsy! (2012) (0)
- THU-262-A modified Glasgow alcoholic hepatitis score incorporating the neutrophil-to-lymphocyte ratio is superior to other baseline scores of prognosis in alcoholic hepatitis (2019) (0)
- PMO-130 Altered acetyl-coa metabolism in hepatic mitochondrial impairment in in vitro models of hepatic cellular steatosis (2012) (0)
- Haematopoietic stem cells are recruited into the liver and contribute to hepatic myofibroblast differentiation in alcohol induced liver injury (2008) (0)
- Media containing lactate, pyruvate, ammonia and octanoate affect mitochondria biogenesis and increase metabolism in the C3A hepatocyte cell line (2005) (0)
- The study of DNA, RNA and proteins using blotting techniques (1991) (0)
- O23 Carvedilol is associated with improved survival in cirrhotic patients; a long term follow up study (2021) (0)
- TIPS for gastric varices. Authors' reply (2003) (0)
- The contribution of alcohol-use disorder to decompensated cirrhosis among people with hepatitis C: an international comparison study (2017) (0)
- RESPONSE TO INTERFERON IN HEMOPHILIACS WITH CHRONIC HCV INFECTION (1995) (0)
- HEPATITIS-C VIRAL GENOTYPES, MODES OF TRANSMISSION, AND INCUBATION OF INFECTION IN HEPATOCELLULAR-CARCINOMA (HCC) (1995) (0)
- Dabos, Konstantinos John and Parkinson, John Andrew and Sadler, Ian Howard and Plevris, John Nicholas and Hayes, Peter Clive (2015) 1H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy (2017) (0)
- Incarceration of People who inject Drugs – Modelling its Role in HCV Transmission and the Impact of Scaled-Up HCV Treatment in Prisons (2016) (0)
- RE: CARDIAC HYPERTROPHY IN LIVER TRANSPLANT RECIPIENTS: TACROLIMUS, CYCLOSPORINE (2003) (0)
- Does 11[beta]HSD1 in visceral adipose tissue (VAT) deliver cortisol to the liver? Studies with portal vein sampling and tracer infusion in humans (2008) (0)
- 1269 OLEATE UPREGULATES LECTIN GALACTOSIDE-BINDING SOLUBLE, 2 (LGALS2) IN MODEL OF CELLULAR STEATOSIS (2011) (0)
- 127 Preconditioning C3A cells for usage in bioartificial liver support systems (2004) (0)
- Prevalence and markers of advanced liver disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study (2011) (0)
- Corrigenda (1812) (0)
- Morphological and functional characteristics of 3D porcine hepatospheroids cultured in a rotary cell culture system (RCCS) compared to conventional 2D static culture. (2000) (0)
- Reply to Dr Larsen (1998) (0)
- TISSUE ENGINEERING VASCULARIZED HUMAN LIVER ORGANOIDS (2011) (0)
- 145 Budd-Chiari syndrome (BCS): The Edinburgh experience (2006) (0)
- Carvedilol is associated with improved survival in patients with liver cirrhosis and ascites (2017) (0)
- Churchill's Pocketbook Of Medicine (1992) (0)
- Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population Methods Patients (0)
- PTU-006 The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose (2012) (0)
- Role of reactive oxygen intermediates (ROI) in the myocardial injury of liver cirrhosis (1998) (0)
- O24 Unbiased clustering of breath signature in NAFLD identifies disease progression high-risk patient phenotype- 5 year study (2022) (0)
- Reduction inrenal bloodflowfollowing acute increase intheportal pressure:evidence forthe existence ofahepatorenal reflex inman? (1997) (0)
- MEASUREMENT OF HUMAN GLUTATHIONE S-TRANSFERASES BY RADIOIMMUNOASSAY (2017) (0)
- Paper alert. (2018) (0)
- Treatment of Hepatitis C in dedicated homeless GP practice by a multidisciplinary team (2018) (0)
- The Scottish Look Back on Acute Liver Failure: Are We as Good as the Best? (2016) (0)
- Paper alert. (2018) (0)
- Paper alert (2021) (0)
- Geographic disparities and socioeconomic determinants in liver transplantation referral at the Scottish Liver Transplant Unit (2020) (0)
- Hepatology and Hepatobiliary Surgery (2008) (0)
- CLEARED Global consortium results highlight regional variation and need for equity in inpatient outcomes in hospitalized patients with Chronic Liver Disease (2022) (0)
- Corrigendum to 'Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs' [J Hepatol 76 (2022) 549-557]. (2022) (0)
- Paper Alert. (2019) (0)
- Hiroshima and Nagasaki (2015) (0)
- P07 Splanchnic steal in patients with liver disease: a 3T MRI study of visceral blood flow (2010) (0)
- Reversal of Fischer’s ratio in an anesthetised porcine model of acute liver failure (2003) (0)
- Excess mortality risk among hepatitis C patients after being “cured” in the interferon-free era: results from three population-based cohorts (2022) (0)
- Paper Alert. (2020) (0)
- Paper alert (2004) (0)
- Paper alert. (2016) (0)
- [726] METABOLIC CHARACTERISTICS OF LEAN TYPE 2 DIABETES PATIENTS WITH ABNORMAL LIVER ENZYMES (2007) (0)
- Paper alert. (2016) (0)
- Paper alert (2019) (0)
- Letter: improve survival in variceal bleeding in cirrhosis—place pTIPS as early as possible after index bleed. Authorsʼ reply (2023) (0)
- Urinary taurine measured by H-1 NMR spectroscopy is increased in patients with chronic liver disease. A useful marker of cirrhosis?. (2000) (0)
- Paper alert. (2018) (0)
- Risk factors for short-term post discharge clinical outcomes in patients hospitalized with decompensated chronic liver disease: interim results from Global CLEARED study (2022) (0)
- Paper alert. (2016) (0)
- Paper Alert. (2019) (0)
- Paper alert (2008) (0)
- Paper alert (2005) (0)
- Paper alert. (2018) (0)
- Guidance document: risk assessment of patients with cirrhosis prior to elective non-hepatic surgery (2023) (0)
- Psychological aspects of liver transplantation (2004) (0)
- Paper alert. (2017) (0)
- Paper alert. (2019) (0)
- alert A selection of interesting papers that were published in the month before our press date in major journals likely to report important results in gastroenterology and hepatology (2016) (0)
- Paper alert (2017) (0)
- Human paracetamol hepatotoxicity is mitigated by the gut-liver axis in vitro (2022) (0)
- Paper alert (2018) (0)
- Stop Hyperventilating, Start Talking (2006) (0)
- Paper alert (2005) (0)
- Extra-Adrenal Cortisol Production in Obese Men with Type Two Diabetes Mellitus - How Big Is the Therapeutic Target for 11 beta HSD1 Inhibitors? (2010) (0)
- Metabolic consequences of an upper gastro-intestinal bleed in patients with cirrhosis (2003) (0)
- Study of acute liver failure in Scotland (2001) (0)
- N-acetylcysteine reduces gluconeogenesis without altering hepatic lipid accumulation or mitochondrial superoxide production in an in vitro model of NAFLD (2009) (0)
- Ultrasound detection of hepatic steatosis in Type 2 diabetes: the Edinburgh Type 2 Diabetes Study (2010) (0)
- Paper alert. (2019) (0)
- 221 CORONARY ARTERY CALCIFICATION SCORES IN THE ASSESSMENT OF PATIENTS FOR LIVER TRANSPLANTATION: ASSOCIATION WITH OTHER CARDIOVASCULAR RISK FACTORS (2008) (0)
- HEPSYS-III PROTEOMICS PROFILING OF IN VITRO CELLULAR STEATOSIS MODEL: THE ROLE OF OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN THE PROGRESSION OF NAFLD (2013) (0)
- Letter to the editor: 'Human based systems: Mechanistic NASH modelling just around the corner?' (2018) (0)
- Patterns of alcohol‐associated liver damage (2015) (0)
- HEPSYS-II METABOLOMICS PROFILING OF AN IN VITRO MODEL OF CELLULAR STEATOSIS: DICARBOXYLIC ACIDS AND EICOSANOIDS AS MARKERS OF ENHANCED LIPID PEROXIDATION AND FATTY ACID OXIDATION DYSREGULATION (2013) (0)
- Gut-liver crosstalk and gut homeostasis in paracetamol toxicity: In Vitro Study Using Impedence-Based Assay (2019) (0)
- 1091 TISSUE ENGINEERING VASCULARIZED HUMAN LIVER ORGANOIDS: STUDY OF MORPHOLOGY, METABOLOMICS AND PHENOTYPIC EXPRESSION OF TRANSITIONAL 2D/3D CO-CULTURES OF HEPATIC C3A CELLS WITH ENDOTHELIAL PROGENITORS (2011) (0)
- American Institute of Ultrasound in Medicine Conference (2009) (0)
- Oleate upregulates lectin galactoside-binding soluble 2 (LGALS2) in in vitro model of cellular steatosis (2011) (0)
- The Effect of Eicosapentaenoic Acid on Hepatic Metabolism and Intracellular Lipid Droplet Dynamics in An in Vitro Model of Hepatic Steatosis (2022) (0)
- Prognostic markers of ourcome in non-acetaminophen overdose fulminant hepatic failure (2003) (0)
- 213 PREVENTING THE PROGRESSION TO CHRONIC KIDNEY DISEASE FOLLOWING LIVER TRANSPLANTATION (2008) (0)
- Medical treatmentofportal hypertension andoesophageal (1983) (0)
- Liver transplants for alcoholic cirrhosis. (1998) (0)
- Explorer ' It ' s been a long haul , a big haul , but we ' ve made it ' : hepatitis C virus treatment in post-transplant patients with virus recurrence : An interpretative phenomenological analysis (2018) (0)
- Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease. (1989) (0)
- The Addition of Vitamin D Supplementation to Interferon and Ribavirin in the Treatment of Hepatitis C Virus Infection: A Randomised Double-Blind Placebo- Controlled Pilot Study (2018) (0)
- Urinary taurine and hippurate are useful markers of alcoholic cirrhosis (2002) (0)
- PTU-005 Circulating levels of neopterin are associated with adverse outcomes following paracetamol-induced acute liver injury (2012) (0)
- Effectiveness of two serum free hormonally defined media in preserving metabolic functions of cultured primary porcine hepatocytes. (2001) (0)
- Unbiased clustering of exhaled breath profiles in metabolic dysfunction-associated fatty liver disease identifies a patient phenotype at higher risk of disease progression (2022) (0)
- 1119 QUANTIFYING THE EXTENT OF CIRRHOSIS ATTRIBUTABLE TO ALCOHOL AMONG PATIENTS CHRONICALLY INFECTED WITH HEPATITIS C: IMPLICATIONS FOR TREATMENT COST-EFFECTIVENESS STUDIES (2012) (0)
- Intra-graft proliferation of naive and memory T lymphocytes during hepatic allograft rejection (1998) (0)
- Increased case‐finding and uptake of direct‐acting antiviral treatment essential for micro‐elimination of hepatitis C among people living with HIV: a national record linkage study (2020) (0)
- Regional variations in the concentrations of ketone bodies in cirrhosis and hepatic encephalopathy (2011) (0)
- The role of alpha-fetoprotein in hepatocellular carcinoma surveillance in a loco-regional Scottish cohort (2012) (0)
- Antimicrobial Prophylaxis Following Liver Transplantation (2021) (0)
- Paper alert. (2018) (0)
- Hepatic Artery Diseases (2008) (0)
- Pollution derived nanoparticles profoundly affects hepatocyte bioenergetics (2006) (0)
- Efficiency of parallel stent placement for the treatment of transjugular intrahepatic portosystemic stent shunt (TIPSS) insufficiency (1998) (0)
- Ketone bodies' metabolism in metabolically stable patients with advanced liver disease (2004) (0)
- PTU-003 Circulating levels of Interleukin-18 correlate with severity following human acute liver injury (2012) (0)
- Serum from fulminant hepatic failure patients impairs C3A cell metabolism through inhibition of mitochondrial function. (2002) (0)
- Murine hepatic versus renal and splenic dendritic cells: The function depends on the environment not the phenotype (2001) (0)
- 215 CHRONIC KIDNEY DISEASE FOLLOWING LIVER TRANSPLANTATION FOR ACUTE LIVER FAILURE (2008) (0)
- Anunusual caseofgustatory sweating (1982) (0)
- ‘It’s been a long haul, a big haul, but we’ve made it’: hepatitis C virus treatment in post-transplant patients with virus recurrence: An interpretative phenomenological analysis (2018) (0)
- Sleep disordered breathing and liver function (2008) (0)
- 476 MELD AND UKELD ARE NOT USEFUL RISK STRATIFICATION TOOLS IN PATIENTS WITH SEVERE PARACETAMOL-INDUCED ACUTE LIVER INJURY (2009) (0)
- LEFT VENTRICULAR FUNCTION IN LIVER CIRRHOSIS. AUTHORS' REPLY (1996) (0)
- Gastroenterology and liver disease (1995) (0)
- Double blind randomised study of effect of simulated bleeding onneutrophil chemotaxis in patients with cirrhosis (2000) (0)
- Percutaneous closure of secundum atrial septal defects with the amplatzer occluder: Early clinical experience and echocardiographic follow-up (2000) (0)
- Transhepatic neutrophil chemotaxis and chemokine concentrations in patients with chronic liver disease. (2001) (0)
- Safety of Propranolol in Portal Hypertension (2012) (0)
- 394 Small bowel capsule endoscopy and portal hypertensive enteropathy in cirrhotic patients : results from a tertiary referral centre (2016) (0)
- Human cord blood cells can differentiate into hepatocytes in the NOD-SCID mouse liver in the absence of cellular fusion (2003) (0)
- Explorer The use of hemostatic spray as an adjunct to the conventional hemostatic measures in high-risk nonvariceal upper GI bleeding (2017) (0)
- Reply to: "Carvedilol and survival in cirrhosis with ascites: A cognitive bias?" (2017) (0)
- PTU-026 Evidence of gut-liver crosstalk and gut homeostasis in paracetamol toxicity:in vitro study using impedance-based assay (2019) (0)
- 468 ALCOHOL INDUCED LIVER INJURY MOBILISES HAEMATOPOIETIC STEM CELLS THAT CONTRIBUTE TO HEPATIC FIBROSIS (2008) (0)
- Cerebral near infrared spectroscopy (NIRS): a novel method for the measurement of indocyanine green (ICG) elimination in the assessment of patients with liver disease (1998) (0)
- Metabolic preconditioning upregulates C3A cell line bioenergetics. (2001) (0)
- Metabolic abnormalities in patients with cirrhosis and hepatic encephalopathy. (2001) (0)
- Explorer Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites (2006) (0)
- 10 years follow-up of 484 patients with transjugular intra-hepatic portosystemic stent-shunt (TIPSS). (2001) (0)
- Acute liver failure leads to apoptosis of engrafting hepatocytes by a reversible down-regulation of hepatocyte beta(1)-integrin activity. (2002) (0)
- Early clinical experience with percutaneous closure of patent foramen ovale with the amplatzer occluder in adults (2000) (0)
- Endothelial injury following liver graft reperfusion, and the role of neutrophils. (1996) (0)
- HEPSYS-I MICROARRAY EXPRESSION PROFILING OF AN IN VITRO 'NUTRIENT EXCESS' MODEL OF NAFLD IN HUMAN HEPATOCYTES (2013) (0)
- Serum hyaluronic acid is an independent predictor of mortality in patients with chronic liver disease (2018) (0)
- ROLE OF SERUM HYALURONIC ACID IN PREDICTING MORTALITY IN PATIENTS WITH CHRONIC LIVER DISEASE (2011) (0)
- P30 ENDOTHELIN-1 RECEPTOR ANTAGONISM IN PATIENTS WITH ADVANCED CIRRHOSIS AND REFRACTORY ASCITES: A PRELIMINARY PLACEBO CONTROLLED CROSSOVER TRIAL (2014) (0)
- Letters from general practitioners to hospitals (1984) (0)
- Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making (2022) (0)
- Moderate hy p o t h e rmia for uncontrolled intracranial hy p e rt e n s i o n i n acute liver failure (1999) (0)
- P53 The contrasting effect of octanoate and oleate on phosphatase and tensin homologue expression in in vitro model of steatosis using HepG2/C3A cells (2010) (0)
- circulatory disturbances of cirrhosis . Acute effect of low dose theophylline on the (0)
- Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication? (2022) (0)
- Reply (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Peter C. Hayes?
Peter C. Hayes is affiliated with the following schools:
